Alan B. Colowick's most recent trade in Alumis Inc. was a trade of 16,104 Common Stock done at an average price of $7.0 . Disclosure was reported to the exchange on April 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alumis Inc. | Alan B. Colowick | Director | Purchase of securities on an exchange or from another person at price $ 6.97 per share. | 01 Apr 2025 | 16,104 | 16,104 | - | 7.0 | 112,309 | Common Stock |
| Alumis Inc. | Alan B. Colowick | Director | Purchase of securities on an exchange or from another person at price $ 7.49 per share. | 01 Apr 2025 | 2,300 | 18,404 | - | 7.5 | 17,235 | Common Stock |
| Personalis Inc | Alan B. Colowick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Harpoon Therapeutics Inc | Alan B. Colowick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 16,456 | 16,456 (0%) | 0% | 0 | Common Stock | |
| Harpoon Therapeutics Inc | Alan B. Colowick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 28,571 | 28,571 | - | - | Director Stock Option (Right to Buy) | |
| Harpoon Therapeutics Inc | Alan B. Colowick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 10,167 | 10,167 | - | - | Director Stock Option (Right to Buy) | |
| Personalis Inc | Alan B. Colowick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 15,035 | 15,035 | - | - | Stock Option (right to buy) | |
| Personalis Inc | Alan B. Colowick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 10,770 | 13,506 (0%) | 0% | 0 | Common Stock | |
| Personalis Inc | Alan B. Colowick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 4,229 | 4,229 | - | - | Stock Option (right to buy) | |
| Personalis Inc | Alan B. Colowick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 2,736 | 2,736 (0%) | 0% | 0 | Common Stock | |
| Harpoon Therapeutics Inc | Alan B. Colowick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2021 | 20,335 | 20,335 | - | - | Director Stock Option (right to buy) |